• 제목/요약/키워드: Bone turnover markers

검색결과 40건 처리시간 0.023초

Changes in Serum Biochemical Markers of Bone Cell Activity in Growing Thoroughbred Horses

  • Inoue, Yoshinobu;Asai, Y.;Ohmori, H.;Fujii, H.;Matsui, T.;Yano, H.
    • Asian-Australasian Journal of Animal Sciences
    • /
    • 제19권11호
    • /
    • pp.1632-1637
    • /
    • 2006
  • We studied the changes in biochemical markers of bone metabolism in growing Thoroughbred horses. Serum osteocalcin (OC), as a marker for bone formation, and carboxy-terminal propeptide of type-I collagen (PICP), as a marker for bone formation, carboxy-terminal telopeptide of type-I collagen (ICTP), as a marker for bone resorption, were determined in nine clinically healthy horses from 3 d to 17 mo of age. The BW and withers height (WH) increased during the study. On the other hand, a rapid reduction in body weight gain (BWG) was observed between 1 mo and 9 mo of age and a rapid reduction in withers height gain was observed between 1 mo and 5 mo of age. The serum markers decreased significantly with increasing age. In particular, dramatic changes in serum markers occurred between 3 d to 1 wk and 5 to 7 mo of age in these horses, which suggests that bone turnover rapidly decreased after birth. On the other hand, the ratio of PICP to ICTP decreased through the experiment. This result suggests that the reduction in bone formation exceeded that of bone resorption. There was a significant correlation between markers and growth parameters, except for the correlation between PICP and BWG on single linear regression analysis. Serum OC and ICTP were affected by the WH in multiple linear regression analysis. These results indicated that the age-related variation in serum biochemical markers of bone metabolism reflected bone growth, but neither BW nor BWG. Therefore, we consider that changes in bone modeling are the major factor affecting the levels of serum biochemical markers by 17 mo of age in horses.

성인초기 여성의 골밀도, 생화학적 골표지자 및 골건강 관련 요인 (Bone Mineral Density, Biochemical Bone Turnover Markers and Factors associated with Bone Health in Young Korean Women)

  • 박영주;이숙자;신나미;신현정;김유경;조윤정;전송이;조인해
    • 대한간호학회지
    • /
    • 제44권5호
    • /
    • pp.504-514
    • /
    • 2014
  • Purpose: This study was done to assess the bone mineral density (BMD), biochemical bone turnover markers (BTMs), and factors associated with bone health in young Korean women. Methods: Participants were 1,298 women, ages 18-29, recruited in Korea. Measurements were BMD by calcaneus quantitative ultrasound, BTMs for Calcium, Phosphorus, Osteocalcin, and C-telopeptide cross-links (CTX), body composition by physical measurements, nutrients by food frequency questionnaire and psychosocial factors associated with bone health by self-report. Results: The mean BMD (Z-score) was -0.94. 8.7% women had lower BMD ($Z-score{\leq}-2$) and 14.3% women had higher BMD ($Z-score{\geq}0$) than women of same age. BTMs were not significantly different between high-BMD ($Z-score{\geq}0$) and low-BMD (Z-score<0) women. However, Osteocalcin and CTX were higher in women preferring caffeine intake, sedentary lifestyle and alcoholic drinks. Body composition and Calcium intake were significantly higher in high-BMD. Low-BMD women reported significantly higher susceptibility and barriers to exercise in health beliefs, lower bone health self-efficacy and promoting behaviors. Conclusion: Results of this study indicate that bone health of young Korean women is not good. Development of diverse strategies to intervene in factors such as exercise, nutrients, self-efficacy, health beliefs and behaviors, shown to be important, are needed to improve bone health.

한국인 성인 여성의 생화학적 골대사지표 및 골밀도와 일반적 특성과의 관계 (Biochemical Bone Turnover Markers, Bone Mineral Density, and General Characteristics in Korean Women)

  • 김화영;허영란
    • 한국식품영양과학회지
    • /
    • 제42권2호
    • /
    • pp.195-202
    • /
    • 2013
  • 본 연구는 20대부터 50대까지의 광주, 전남에 거주하는 180명의 건강한 성인 여성을 대상으로 진행되었다. 골대사지표로 골형성지표인 BAP와 OC, 골흡수지표인 NTx를 측정하였으며 골밀도로는 T-score를 이용하였다. 일반적 특징으로 영향 요인으로 연령, 음주, 신체 활동량, 골다공증에 대한 가족력, 폐경, 건강기능성식품 섭취 여부, BMI, 체지방률을 분석하였다. 연령에 따라 비교했을 때 BAP와 OC는 20대가 다른 나이군에 비해 낮았고 음주군은 비음주군에 비해 BAP가 더 높았다. 활동 정도에 따라서는 차이가 없었고 골다공증에 대한 가족력이 있는 군은 골다공증에 대한 가족력이 없는 군에 비해 BAP가 더 높았다. 또한 폐경군은 폐경전군에 비해 BAP가 더 높았으며 건강보조식품 섭취 여부에 따라서는 생화학적 골대사지표나 골밀도의 차이가 없었다. BMI에 따라서는 생화학적 골대사지표 및 골밀도의 차이가 없었지만 체지방률에 따라 분류했을 때는 정상군에 비해 비만군의 BAP가 더 높았고 골밀도는 더 낮았다. 이상의 결과로 보아 노령군, 음주, 골다공증에 대한 가족력, 폐경, 비만이 있는 경우 골형성지표가 증가하였고 특히 비만군에서 골밀도가 낮은 것을 확인하였다. 따라서 골대사지표로 보았을 때, 한국인 여성들은 골 건강을 위해서 나이가 증가함에 따라 음주 및 비만 관리가 중요함을 시사하였다.

갱년기 유도 흰쥐에서 감태 추출물이 골 대사 지표물질의 변화에 미치는 영향 (The Effect of Ecklonia cava Extracts on Bone Turnover Markers in Ovariectomized Rats)

  • 강성림;김미향
    • 생명과학회지
    • /
    • 제19권12호
    • /
    • pp.1841-1846
    • /
    • 2009
  • 갱년기의 여성에는 여러 폐경 증후들이 나타나는데, 특히 에스트로겐의 감소로 인한 골 손실의 증가 등으로 골다공증질환의 발병율이 높아지게 된다. 이러한 갱년기 증후군을 치료하기 위해 호르몬 대체 요법으로 치료를 하고 있으나 유방암과 자궁암 등의 부작용에 대한 논쟁의 여지가 있어 갱년기 증후군을 치료하는데 양면성을 가진다. 그러므로 본 연구에서는 쉽게 섭취 할 수 있으며, 부작용이 없는 해조류인 감태 추출물을 이용하여 in vivo 실험을 통해 갱년기 장애 시 나타날 수 있는 골 손실에 미치는 영향을 검토하였다. 난소 절제술을 시행한 군들에서 전체적으로 체중이 증가하였으나, 난소절제 후 감태 추출물을 투여에 의한 체중 감소는 나타나지 않아 감태 추출물이 체중 감소에는 크게 영향을 미치지 않은 것으로 나타났다. 난소절제 시(OVX-CON) 에스트로겐 결핍으로 bone turnover가 증가되어 비 난소절제(SHAM)군에 비해 혈장 중의 ALP의 활성이 증가되었으나, 난소 절제 후 감태 추출물을 투여한 군에서 그 활성이 유의적으로 감소하는 경향이 나타났다. 이것은 난소 절제 후 에스트로겐의 분비가 감소되는데 반해 감태 추출물 투여가 에스트로겐 대체 작용을 함으로써 난소절제로 인한 골 손실 정도를 완화시켜 준 것으로 추측되어진다. 골 용해 지표인 혈액 중의 CTx는 난소절제군이 비 절제군에 비해 높은 수준을 보여 난소 절제군에 있어 골 용해가 증가되었음을 나타내었다. 반면 감태 추출물의 투여로 인해 CTx 함량이 감소하였으며, EC-200군의 경우 SHAM과 비슷한 수준으로 나타났다. 이는 난소절제로 인해 bone turnover가 증가된 상태에서 감태 추출물의 투여로 bone turnover가 감소하여 골 흡수 저해 효과를 타나낸 것으로 추정된다. 또한 결합조직 중의 collagen 함량은 난소절제로 인하여 감소하였으나, 감태 추출물의 투여에 의해 점진적으로 회복되는 경향을 나타내었다. 이상의 결과로부터 estrogen 부족으로 인한 골 손실의 예방에 감태가 유익한 효과를 가지며, 이를 활용한 기능성식품 개발도 가능할 것으로 기대되어 진다.

스트렙토조토신 유발 당뇨병 백서에서 실험적 치아이동중의 치조골 교체 (Alveolar bone turnover during experimental tooth movement in Streptozotocin-induced diabetic rat)

  • 이기수;이택우;김성진
    • 대한치과교정학회지
    • /
    • 제31권3호
    • /
    • pp.357-367
    • /
    • 2001
  • 당뇨병 흰쥐를 대상으로 치조골의 교체(turnover)와 치아 이동 중 치조골의 흡수와 형성의 활성을 비교 관찰하기 위하여 8주령의 웅성 Sprague-Dawley계 흰쥐를 정상대조군(N), 당뇨군(D), 정상-치아이동군(N-tm), 당뇨-치아이동군(D-tm)으로 나누고, 각 실험군은 치아이동 실험 1일, 3일, 7일, 14일의 소군으로 나누었다. 당뇨병은 치아이동 실험 18일전에 스트렙토조토신(50mg/체중 kg)을 꼬리정맥에 단 회 주사하여 유발하였다. 치아이동은 상악 제1대구치를 초기 교정력 40그램으로 근심 이동시켰다. 상악 제1대구치 주위 치조골을 대상으로 골형성 징후표지로서 치조골 alkaline phosphatase(ALP)와 osteocalcin(OC)을, 골흡수 징후표지로서 acid phosphatase (ACP)와 tartrate-resistant acid phophatase(TRAP)을 정량 분석하였으며, D군과 N군에서는 이들의 혈중 농도를 정량 분석하였다. 1. D군의 혈청 TRAP농도와 혈청 OC농도는 모든 실험 경과군에서 N군보다 감소하였고(p<0.05), 당뇨기간이 길어질수록 더 많이 감소한 것으로 나타났다. 또한 치조골 흡수 징후표지는 감소하는 경향이었으며 골형성 징후표지도 실험기간이 경과함에 따라 더 많이 감소하는 것으로 나타났다. 2. N-tm군의 치조골 ACP농토와 TRAP농도는 N군과 비교하여 1일과 3일군에서 가장 높았으며(p<0.01), 그 이후 감소경향을 나타냈고, 치조골 OC함량은 3일, 7일 14일군에서 N 군보다 높았다(p<0.001). 그러나 D-tm군에서 치조골 ACP와 TRAP농도는 정상 N군에 비하여 1일에는 낮으나 7일, 14일 경과군에서 가장 높았고(p<0.001), 실험 경과에 따라 계속 증가 하였으며(p<0.001), 치조골 ALP와 OC 함량은 3일 경과 후부터 증가하지만 정상 N군과 유의차가 없었다. 3. 당뇨-치아이동군의 치아이동량은 정상-치아이동군보다 많은 것으로 나타났다. 이러한 실험 결과는 당뇨병의 전신 골격과 치조골은 골 흡수 활성이 억제되어 있으며 골형성 활성은 당뇨 지속시간이 길어질수록 더 많이 억제되는 느린 골교체를 하며, 교정력에 의한 치조골 흡수활성이 처음 높아지는 시기는 정상치아이동시보다 늦고 더 오랬 동안 지속되며 치조골 형성활성은 낮고, 치아 이동량은 증가하며 이동중 치아동요도가 증가함을 시사한다.

  • PDF

Can bone marrow aspirate improve mandibular fracture repair in camels (Camelus dromedarius)? A preliminary study

  • Al-Sobayil, Fahd;Sadan, Madeh A.;El-Shafaey, El-Sayed;Ahmed, Ahmed F.
    • Journal of Veterinary Science
    • /
    • 제21권6호
    • /
    • pp.90.1-90.11
    • /
    • 2020
  • Background: Mandibular fractures are common in camels, leading to considerable economic losses. This study explored methods of improving mandibular fractures repair, adjuvant with interdental wire, or bone plate fixation. Autologous bone marrow (BM) injection enhances osteogenesis and rapid healing. Objectives: To investigate the effect of autologous BM aspirate as an adjuvant treatment for repairing mandibular fractures in camels with interdental wire, or bone plate fixation. Methods: Thirty dromedary camels aged 5-8 years and of both sexes were randomly divided into 4 treatment groups: group 1 (n = 10) treated with stainless steel wire fixation and BM injection at the fracture line, group 2 (n = 10) treated with plate fixation and BM injection at the fracture line, group 3 (n = 5) treated with stainless steel bone wire fixation and placebo saline injection at the fracture line, and group 4 (n = 5) treated with plate fixation and placebo injection at the fracture line. The mandibular fractures were followed weekly for 12 weeks postoperatively to assess improvement and healing based on clinical evaluation, radiographic union scale, and bone turnover markers (i.e., bone alkaline phosphatase, osteocalcin, pyridinoline, and deoxypyridinoline). Results: Compared to other groups, elevated bone turnover markers in group 1 were demonstrated (p < 0.05) on the seventh postoperative day. Likewise, compared to other groups, both clinical findings and radiographic union scale significantly improved (p < 0.05) in group 1 on the 56th postoperative day. Conclusions: BM aspirate has a promising beneficial osteogenic effect on mandibular fracture repair in camels, most notably when combined with interdental wire fixation.

임상가를 위한 특집 2 - Bisphosphonate-related osteonecrosis of the jaw(BRONJ)에 대한 biochemical bone markers와 악골괴사와 연관된 nonbisphosphonate drugs (Biochemical bone markers of bisphosphonate-related osteonecrosis of the jaw (BRONJ) and nonbisphosphonate drugs in osteonecrosis of the jaw)

  • 이덕원;이현우;권용대
    • 대한치과의사협회지
    • /
    • 제52권4호
    • /
    • pp.203-217
    • /
    • 2014
  • Bisphosphonates are widely used in the treatment of many medical conditions, such as osteoporosis, multiple myeloma, Paget's disease, etc. However, side effect has been documented in the published data during the past years, osteonecrosis of the jaw in patients receiving long-term bisphosphonate therapy. Although pathogenesis of BRONJ(bisphophonate-related osteonecrosis of the jaw) is not yet fully understood, it is currently known to be a disease associated with suppressed bone turnover by bisphopbonate. Recent literature has indicated a similar association with nonbisphosphonate drugs used in cancer therapy including monoclonal antibodies denosumab and bevacizumab and multikinase inhibitor sunitinib. Accordingly, many studies have been carried out on the biochemical markers examination to assess the risk for BRONJ. The treatment of BRONI is reported with a review of the relevant literature. However, there is still a controversial discussion about the adequate treatment. It is necessary to accumulate further studies in order to establish more useful biochemical markers and effective treatment for BRONJ.

Effects of Dietary from Safflower Bud on the Osteoporosis in Ovariectomized Rats

  • Lim, Seul Ki;Kim, Dong Il;Park, Min Jung;Choi, Joo Hee;Kim, Young Kuk;Lee, An Chul;Choi, Mi Young;Park, Soo Hyun
    • 대한의생명과학회지
    • /
    • 제20권3호
    • /
    • pp.156-161
    • /
    • 2014
  • It has been reported that safflower seeds have preventive effects against osteoporosis. Recently, safflower buds (SB) were found to have more useful functional ingredients than safflower seeds. In the current study, we evaluated the anti-osteoporosis effects of SB diet in ovariectomized (OVX) rats. The rats were divided into five groups; sham operated group, OVX alone group, OVX plus $17{\beta}$-estradiol ($E^2$ $10{\mu}g/kg$, i.p.) and OVX plus SB diet feeding group (0.3% or 1%). Feeding of SB diet (0.3% or 1%) to OVX rats markedly increased bone mineral density (BMD) of femurs, compared to the OVX group. The OVX rats exhibited a marked increase in trabecular separation (Tb.Sp) and this change was inhibited by the feeding of SB diet, similar to that seen with OVX+E2 group. Moreover, feeding of SB diet to OVX rats decreased the markers of bone turnover, including osteocalcin and alkaline phosphatase (ALP). These results suggest that SB extract has a bone sparing effect in OVX-induced trabecular bone loss and prevents deterioration of bone microarchitecture by suppressing the rate of bone turnover. Therefore, SB may be useful for preserving bone mass and structure in estrogen deficient women with a potential role in reducing postmenopausal osteoporosis.

Romosozumab의 효과 및 심혈관계 안전성: 체계적 문헌고찰 및 메타분석 (Efficacy and Cardiovascular Safety of Romosozumab: A Meta-analysis and Systematic Review)

  • 최서용;김정민;오상현;천승현;정지은
    • 한국임상약학회지
    • /
    • 제33권2호
    • /
    • pp.128-134
    • /
    • 2023
  • Background: This systematic review and meta-analysis aimed to evaluate the efficacy and cardiovascular safety of romosozumab compared with placebo. Methods: Randomized controlled trials (RCTs) were searched from Medline, EMBASE, Cochrane Central, and Web of Science until July 2022. Primary outcomes included the change in bone mineral density (BMD) from baseline at month 6. The secondary outcomes were the change of bone turnover markers (N-terminal propeptide of type 1 procollagen (P1NP); C-terminal telopeptide of type 1 collagen (CTX)) from baseline at month 3, and the incidence of cardiovascular adverse events for the total follow-up period. Results: A total of 7 RCTs on 8,370patients were included. Romosozumab showed better effects in improving BMD in both lumbar spine and femoral neck at month 6 (standardized mean difference, SMD 2.20 [95% CI: 1.89-2.52], SMD 0.63 [95% CI: 0.41-0.86]). In contrast to placebo, romosozumab significantly increased PINP levels and reduced CTX levels at month 3 (SMD 0.93 [95% CI: 0.65-1.22], SMD -1.03 [95% CI: -1.23~ -0.82]. However, there was no significant difference in the composite incidence of cardiovascular adverse events and major adverse cardiovascular events (OR 1.16 [95% CI: 0.82-1.65], OR 1.08 [95% CI: 0.75-1.56]). Conclusion: This analysis showed that romosozumab significantly improved BMD compared to placebo and was beneficial for change in bone turnover markers. There is no significant difference in the incidence of cardiovascular adverse events compared to placebo.

폐경 후 여성의 골격상태에 영향을 미치는 요인분석 (Some Factors Affecting Bone Mineral Status of Postmenopausal Women)

  • 오세인;이행신;이미숙;김초일;권인순;박상철
    • 대한지역사회영양학회지
    • /
    • 제7권1호
    • /
    • pp.121-129
    • /
    • 2002
  • Osteoporosis, the typical metabolic bone disease of the elderly, is characterized by a reduction in bone mineral density (BMD) and increased fracture risk. Genetic and environmental factors are known to play a key role in bone metabolism, and diet is also considered to be one of the important factors. The purpose of the present study was to investigate the relationship among the factors affecting BMD, including stature, body weight, age, time period since onset of menopause, and biochemical markers of bone turnover in postmenopausal women. Seventy-eight postmenopausal women who visited health promotion center for health examinations volunteered to participate in this study and they were divided into two groups according to the time period since onset of menopause : women with a time period since onset of menopause of less than 5 years (Group 1) and women with a time period since onset of menopause of 5 years or more (Group 2). The demographic characteristics and dietary intake were surveyed using a questionnaire. BMDs of the lumbar spine and femoral neck of subjects were measured by dual energy X-ray absorptiometry. Serum levels of 25-hydroxy-vitamin D and parathyroid hormone (PTH), known to be indicators of bone related hormone status, were anlyzed. Serum samples were measured for calcium, phosphorus, alkaline phosphatase, and osteocalcin as bone formation indicators, and urine was analysed for deoxypyridinoline, creatinine, calcium, and sodium as bone resorption indicators. The results are as follow : The mean BMDs of the lumbar spin and femoral neck were $1.02 \pm 0.02 g/cm^2 and 0.81 \pm 0.02 g/cm^2 respectively, and the BMD level of Group 2 was significantly lower than tat of Group 1 (p<0.01, p<0.05, respectively). The mean daily intake of energy was 1838 $\pm$ 55 kcal. When nutrient intake was compared with the recommended dietary allowances (RDA) of the subjects, only calcium, vitamin A and riboflavin intake showed means lower than the RDA. The nutrient intake did not show any significant differences between Group 1 and 2 Serum and urine levels of biochemical markers of bone turnover did not show any significant differences between Group 1 and 2, and all were within the normal range. However, the PTH and deoxypyridinoline levels showed a tendency to be higher, and the osteocalcin level to be lower in Group 2 than in Group 1. Although age and years after menopause (YAM) showed negative correlations with lumbar spine bone mineral density (LBMD) (r= -0.38, p<0.001, and r= -0.26, p< 0.05, respectively), no correlation was found with femoral neck bone mineral density (NBMD). While height, body weight and body mass index (BMI) showed a positive correlation with LBMD (r= 0.32, p<0.001, r= 0.38, p<0.001, r= 0.22, p= 0.05, respectively), only body weight and BMI showed a positive correlation with NBMD (r= 0.30, p<0.01, and r= 0.27, p<0.05, respectivley). There was no significant corealtion between BMDs and the nutrient intake of subjects, except in the case of carbohydrates (r= 0.22, p<0.05). Also, serum and urine levels of bone turnover markers showed no significant correlation with nutrient intake. On the other hand, serum osteocalcin had a positive correlation with vitamin C intake (r= 0.22, p= 0.05), and urine deoxypyridinolin showed a negative correlation with niacin intake (r= -0.22, p= 0.05). Urinary na was negatively correlated with protein intake(r= -0.23, p= 0.05). The results suggested that it is difficult to prevent the decrease in bone mass among postmenopausal women eating the usual Korean diet. However, the BMDs of the lumbar spine and femoral neck were positively related to body weight ad BMI in postmenopausal women. Therefore, this study confirmed that one of the most effective ways to minimize bone loss in postmenopausal women would be to maintain an adequate body weight with balanced nutrient intake and activity in the pre-and postmenopausal periods.